Notice of first launch, interruption or termination of supply of a human drug
 DateHolderCode ▲DrugDate fromSubject
 4.1.2023Viatris Limited (VIM)9997COgivri 150 mg prášok na infúzny koncentrát (plc ifc 1x150 mg (liek.inj.skl.))5.1.2023R
 10.3.2023Viatris Limited (VIM)9997COgivri 150 mg prášok na infúzny koncentrát (plc ifc 1x150 mg (liek.inj.skl.))10.3.2023O
 4.7.2023Zentiva, k.s. (ZNT-1)9996DLevosimendan Zentiva (con inf 1x5 ml/12,5 mg (liek.skl.inj.))4.7.2023O
 4.2.2025Zentiva, k.s. (ZNT-1)9996DLevosimendan Zentiva (con inf 1x5 ml/12,5 mg (liek.skl.inj.))4.2.2025R
 14.3.2025Zentiva, k.s. (ZNT-1)9996DLevosimendan Zentiva (con inf 1x5 ml/12,5 mg (liek.skl.inj.))14.3.2025O
 31.5.2023Zentiva, k.s. (ZNT-1)9996DLevosimendan Zentiva (con inf 1x5 ml/12,5 mg (liek.skl.inj.))31.5.2023R
 20.12.2022Zentiva, k.s. (ZNT-1)9996DLevosimendan Zentiva (con inf 1x5 ml/12,5 mg (liek.skl.inj.))20.12.2022U
 8.8.2023Zentiva, k.s. (ZNT-1)9996DLevosimendan Zentiva (con inf 1x5 ml/12,5 mg (liek.skl.inj.))8.8.2023R
 23.8.2023Zentiva, k.s. (ZNT-1)9996DLevosimendan Zentiva (con inf 1x5 ml/12,5 mg (liek.skl.inj.))24.8.2023O
 10.2.2025Biosimilar Collaborations Ireland Limited (BTT)9996CFulphila 6 mg injekčný roztok naplnený v injekčnej striekačke (sol inj 1x0,6 ml/6 mg (striek.inj.napl.skl. s chráničom ihly))10.2.2025R
 22.9.2024Biosimilar Collaborations Ireland Limited (BTT)9996CFulphila 6 mg injekčný roztok naplnený v injekčnej striekačke (sol inj 1x0,6 ml/6 mg (striek.inj.napl.skl. s chráničom ihly))20.9.2024R
 13.2.2024Sandoz Pharmaceuticals d.d. (SAN-SLO-1)99949Ciprofloxacín Sandoz 500 mg filmom obalené tablety (tbl flm 20x500 mg (blis.PP/Al))12.2.2024O
 3.2.2025Sandoz Pharmaceuticals d.d. (SAN-SLO-1)99949Ciprofloxacín Sandoz 500 mg filmom obalené tablety (tbl flm 20x500 mg (blis.PP/Al))31.1.2025R
 31.5.2023Sandoz Pharmaceuticals d.d. (SAN-SLO-1)99949Ciprofloxacín Sandoz 500 mg filmom obalené tablety (tbl flm 20x500 mg (blis.PP/Al))31.5.2023R
 16.9.2024Sandoz Pharmaceuticals d.d. (SAN-SLO-1)99949Ciprofloxacín Sandoz 500 mg filmom obalené tablety (tbl flm 20x500 mg (blis.PP/Al))1.9.2024R

Subject means:
U-Placement of medicine to Slovakian market, R-Discontinuation of medicine supply to Slovakian market,
O-Resumption of medicine supply to Slovakian market, Z-Cancelation of medicine supply to Slovakian market


Date from
From
To



 
Processed by the system MCR.Prerusenie (8.0)